HMGB1 and colorectal carcinoma: Similarly, CRC patients with strongly positive nuclear HMGB1 expression had a better RFS than those whose nuclear HMGB1 expression was not strongly positive, although the data did not support an unequivocal association (Fig. 2B, P = 0.054).